Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Determination of Accuracy and Precision of Lesion Uptake Measurements in Human Subjects with Time-of-Flight PET

Margaret E. Daube-Witherspoon, Suleman Surti, Amy E. Perkins and Joel S. Karp
Journal of Nuclear Medicine April 2014, 55 (4) 602-607; DOI: https://doi.org/10.2967/jnumed.113.127035
Margaret E. Daube-Witherspoon
1Department of Radiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suleman Surti
1Department of Radiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy E. Perkins
2Philips Healthcare, Cleveland, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel S. Karp
1Department of Radiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Inclusion of time-of-flight (TOF) information in PET reconstructions has been demonstrated to improve image quality through better signal-to-noise ratios, faster convergence, better lesion detectability, and better image uniformity. The goal of this work was to assess the impact of TOF information on the accuracy and precision of quantitative measurements of activity uptake in small lesions in clinical studies. Methods: Data from small (10-mm diameter) spheres were merged with list-mode data from 6 healthy volunteers after injection of 18F-FDG. Six spheres having known activity uptake with respect to the average whole-body uptake were embedded in both the liver and the lung of the subject’s data. Images were reconstructed with TOF information and without TOF information (non-TOF reconstruction). The measured uptake was compared with the known activity; variability was measured across 60 bootstrapped replicates of the merged data, across the 6 spheres within a given organ, and across all spheres in all subjects. Results: The average uptake across all spheres and subjects was approximately 50% higher in the lung and 20% higher in the liver with TOF reconstruction than with non-TOF reconstruction at comparable noise levels. The variabilities across replicates, across spheres within an organ, and across all spheres and subjects were 20%–30% lower with TOF reconstruction than with non-TOF reconstruction in the lung; in the liver, the variabilities were 10%–20% lower with TOF reconstruction than with non-TOF reconstruction. Conclusion: TOF reconstruction leads to more accurate and precise measurements, both within a subject and across subjects, of the activity in small lesions under clinical conditions.

  • instrumentation
  • PET
  • research methods
  • positron emission tomography
  • time-of-flight PET

The benefit of including time-of-flight (TOF) information in the reconstruction of PET data was demonstrated in the 1980s (1–3), when TOF PET scanners were first developed, and followed the predictions of reduced variance (4–6). The gain obtained with TOF reconstruction was characterized by an improved signal-to-noise ratio, with higher gains being predicted for larger objects and better timing resolution. Since the resurgence of interest in TOF information in the last decade and the subsequent development of commercial TOF PET systems (7–9), the advantages of reconstruction with TOF information over reconstruction without TOF information (non-TOF reconstruction) have been studied more thoroughly through simulation and measurement with iterative reconstruction methods (10–22). Iterative TOF PET reconstruction of simulated phantoms (10) resulted in faster and more uniform convergence of contrast recovery that improved further with better timing resolution; this faster convergence with TOF reconstruction resulted in contrast recovery that was higher than that achieved with non-TOF reconstruction at similar noise levels. Measurements of the TOF benefit in physical phantoms showed higher contrast recovery of small lesions with TOF reconstruction for a large uniform phantom at matched noise (11). In clinical studies, the contrast recovery of lesions having unknown uptake was higher with TOF reconstruction than with non-TOF reconstruction for all subjects, and the gain in contrast recovery with TOF reconstruction increased with patient mass (11). In a visual assessment of the TOF benefit in patient studies, Lois et al. (14) showed that images reconstructed with TOF had better definition of small structures, better uniformity, less noise, and higher lesion contrast. Using a prototype scanner with better timing resolution (23), we showed higher contrast recovery with reduced variability across the object and with reduced sensitivity to potential errors in the corrections (e.g., the scatter estimate) (15). Other groups have also remarked on the decreased sensitivity to inconsistencies in the data or corrections with TOF reconstruction (24,25).

The impact of TOF reconstruction on lesion detection has also been investigated with numeric and human observers. TOF information was shown to improve lesion detectability with numeric observers for spheric lesions in simple uniform cylindric phantoms (12,18). Kadrmas et al. (13,20) found improved lesion detectability with TOF reconstruction in 2 sizes of physical anthropomorphic phantoms containing spheric lesions by using localization receiver-operating-characteristic analysis with both numeric and human observers; they found a greater TOF impact for the larger phantom. More recently, the benefit of TOF reconstruction for lesion detectability was demonstrated with both numeric and human observers for clinical whole-body patient data with embedded artificial lesions, especially for low-contrast lesions or large subjects (16,17,22).

The goal of this work was to adapt the sphere insertion technique used in our lesion detectability studies to assess the impact of TOF information on both the accuracy and the precision of the measurement of uptake in lesions in clinical PET data. The power of this technique is that it combines the advantages of a phantom study, where truth is known, with the nonuniform activity and attenuation distributions seen in patient studies.

MATERIALS AND METHODS

TOF Scanner

Data were acquired with the University of Pennsylvania prototype TOF PET scanner, based on LaBr3 scintillators (15,23). This fully 3-dimensional scanner comprises 24 modules of 1,620 crystals (4 × 4 × 30 mm) in a 93-cm-diameter ring. The transverse field of view is 57.6 cm; the axial field of view is 19.2 cm. The intrinsic timing resolution of the scanner, measured with a point source in air, is 375 ps. The energy resolution of 6.5% after energy calibration allows the lower energy threshold to be raised to 470 keV. Data are acquired in list mode with 25-ps timing bins to preserve timing and spatial resolutions. The spatial resolution of the scanner is 5.8 mm (full width at half maximum) at a 1-cm radius.

Data Reconstruction and Corrections

The image reconstruction algorithm was the 3-dimensional list-mode iterative ordered-subsets expectation maximization (OSEM) algorithm (26,27) with a TOF kernel applied in both the forward projection and the backprojection operations (28). The TOF response function was modeled as a 1-dimensional gaussian function along the line of response. All physical effects were incorporated into the system model of the reconstruction. Resolution modeling to compensate for detector blurring was not explicitly included in the reconstruction; instead of voxels, however, modified Kaiser–Bessel (“blob”) basis functions (29,30) were used to constrain the image to be a continuous function during reconstruction. Blob basis functions control image noise without the need for postfiltering while maintaining spatial resolution (30), albeit in a spatially invariant manner. The blobs used for this study had a 7.5-mm radius placed on a 6-mm body center cubic grid (shape parameter, 8.63). The final image was interpolated to 2 × 2 × 2 mm voxels. All TOF OSEM reconstructions had 25 chronologically ordered subsets. Although clinical TOF reconstructions are typically stopped after 4 or 5 iterations, in this study the data were reconstructed for up to 20 iterations to determine the convergence with clinical data.

A rotating line source was used to correct the measured timing differences between crystals (23). Attenuation correction was performed by use of transmission imaging with a rotating 137Cs point source (31). The model-based single scatter simulation was extended to estimate the 4-dimensional scatter distribution in the radial and TOF domains (32,33). The scatter estimate used in non-TOF reconstructions was derived from the 4-dimensional single-scatter simulation–TOF scatter sinogram by compression of the sinogram along the time domain. Random coincidences were estimated by use of the delayed coincidence window technique with the smoothing technique of Casey and Hoffman (34).

Healthy Volunteer Studies

The institutional review board of the University of Pennsylvania approved this study, and all subjects signed written informed consent forms before the study. Six healthy volunteers (5 men and 1 woman; body mass index, 25–38) were injected with 555 MBq (15 mCi) of 18F-FDG and scanned after an average 105-min uptake period. Four frames were acquired to cover the region from the neck to the pelvis. The patient bed was moved between frames to allow for nearly 50% overlap of bed positions to ensure uniform axial noise behavior. The scan duration for each subject was chosen to provide counts comparable, on average, to the events measured in a 2-min–per–frame clinical 18F-FDG study on a Philips Gemini TF TOF PET scanner with our standard 60-min postinjection protocol. Totals of 115–270 megacounts (prompts) and 45–100 million counts (true events) were acquired in the 4-frame studies, in which the ranges in counts were the ranges seen across the 6 subjects.

Sphere Insertion Methodology

To assess the impact of TOF information on the accuracy and precision of sphere uptake measurements in clinically realistic conditions, we inserted spheres with known uptake into the measured healthy volunteer data. El Fakhri et al. (16) and Surti et al. (17) developed a technique for merging list-mode data from spheric lesions measured in air with data from patients for their studies on lesion detectability. In those studies, spheres were embedded at an activity ratio calculated with respect to the local activity in the organ. For this work, their technique was modified to insert spheres having known activity with respect to the average whole-body uptake, similar to a fixed standardized uptake value.

Spheres (10-mm diameter; 1-mm wall thickness) were scanned in air at 77 locations throughout the scanner field of view (radius, 0–12 cm; z-axis, 0 ± 4 cm from the center of the scanner), and the data were stored in list-mode format. Spheres were selected for insertion into the liver and lung regions of the healthy volunteer data such that no 2 spheres were closer than 3.5 cm from center to center. A total of 6 spheres were chosen for each organ.

The desired ratio (ao) of sphere uptake to the average whole-body activity concentration was 10:1. The average whole-body uptake per volume (BWB) was determined by averaging all voxels inside the body in the image after 20 iterations of list-mode TOF OSEM. The transmission image was used to define the interior of the body for this calculation. Voxels in slices within 28 mm of the ends of the whole-body image were excluded from the calculations because those slices were noisy as a result of low slice sensitivity near the ends of the axial field of view.

The procedure for calculating the number of sphere events to insert is illustrated in Figure 1. The desired total sphere activity (A) at the location of each sphere isEmbedded ImageEq. 1where Vsph is the volume of the sphere; ao was 10 for this study. However, the whole-body image before sphere insertion had some background activity in the region of the sphere (Ab,i); therefore, the total activity to be inserted into the healthy volunteer data for sphere i (Ai) is given byEmbedded ImageEq. 2The number of list-mode events to be inserted for sphere i (Embedded Image) was calculated by scaling Ai by the ratio of the number of events in the sphere dataset (Embedded Image) to the total activity (Atot,i) in the sphere-in-air image as follows:Embedded ImageEq. 3

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Schematic of sphere insertion process for list-mode data. Sphere activity to insert (Ai) depends on desired activity ratio (ao) with respect to average whole-body (WB) uptake per unit volume (BWB), reduced by activity already present in patient image at location of sphere (Ab,i). Sphere-in-air data were acquired at known locations on grid (photograph). Sphere data were reconstructed, and ratio of sphere-in-air list-mode events to total sphere image activity (Embedded Image) was used to scale Ai to determine number of list-mode events (Embedded Image) that would generate that activity. These list-mode events were reduced by sampling of probability of attenuation by body for line of response of given event and then were merged with subject’s list-mode data (⊕). This procedure was adapted from that used in earlier lesion detectability studies (16,17).

This scaling undoes any geometric efficiency corrections performed during reconstruction (e.g., solid-angle correction).

To compensate for attenuation effects seen in the whole-body study but not present in the sphere-in-air data, the selected sphere events were reduced by rejecting events through random sampling of the probability of attenuation by the body for the line of response of each sphere event. The “attenuated” sphere events were then merged with the healthy volunteer data by random insertion into the subject’s list-mode data stream. The net result was an increase in the total number of events of less than 1%. This technique implicitly includes partial-volume blurring of the sphere but does not include wall effects. Unlike physical spheres in phantom measurements, the sphere wall does not displace activity around the sphere because counts are present in the subject’s data in the region of the sphere wall; this scenario results in the insertion of effectively wall-less lesions into the clinical data. The merged list-mode data were then reconstructed with TOF information and without TOF information as described earlier.

The sphere insertion process was validated by scanning a 35-cm cylinder that had 5 physical spheres (10-mm diameter; 6:1 activity ratio) located at radial positions from 0 to 11 cm. Fifteen additional 10-mm-diameter spheres were inserted into the phantom data in accordance with the procedure described earlier, with an ao of 6. The data were reconstructed with list-mode TOF OSEM for 20 iterations. Volumes of interest (VOIs; 10-mm diameter) were drawn on the spheres, and the background activity was determined by averaging all voxels inside the phantom image without inserted spheres, analogous to BWB. The average uptake in the physical spheres divided by the background activity was 2.37 ± 0.13 (mean ± SD; range, 2.19–2.48); the average uptake in the inserted spheres was 2.51 ± 0.14 (range, 2.29–2.69). The slightly higher (<10%) uptake measured in the inserted spheres than in the physical spheres can be explained by and is consistent with the findings for wall-less spheres compared with spheres having glass walls (35).

Bootstrapped Replicates

To determine the statistical variability of the measured sphere uptake for TOF and non-TOF reconstructions, we generated 60 replicates of the list-mode data with and without inserted spheres by using bootstrapping as proposed by Haynor and Woods (36) and as demonstrated and validated by Dahlbom (37) and Buvat (38). Bootstrapping permits an assessment of the statistical variability in TOF and non-TOF images at clinically realistic noise levels.

Analysis

Sphere uptake was calculated for VOIs with a 10-mm diameter. The VOI centers were determined from the sphere-in-air reconstructions, and the same VOIs were used on the images reconstructed from the merged sphere and subject data. The sphere VOIs (VOIsph) were normalized by the average whole-body uptake (BWB) after 20 iterations to define a normalized uptake ratio (NUV):Embedded ImageEq. 4BWB was calculated separately for TOF images and non-TOF images to compensate for differences in calibration for TOF and non-TOF reconstructions. Without partial-volume effects, the NUV for each sphere should be 10 (i.e., equal to ao). Because no resolution modeling was included in the reconstruction, the measured NUV was less than 10.

From the 60 replicates of the 6 patient studies with 6 inserted spheres in the lung and liver, we calculated 4 measures.

1. The average NUV for 1 replicate across all subjects and spheres for each organ j (NUVj) was calculated asEmbedded ImageEq. 5where Embedded Image is the uptake in organ j of sphere s in subject p for 1 replicate. This quantity was not averaged across all replicates because each bootstrapped replicate was derived from the same dataset (37).

2. The statistical variability of sphere uptake across the 60 bootstrapped replicates, expressed as the percentage coefficient of variation and averaged across all subjects and spheres for each organ j (Embedded Image), was calculated asEmbedded ImageEq. 6where NUVj(r,s,p) is the uptake in organ j of sphere s in subject p for replicate r.

3. The variability of sphere uptake across sphere locations for the 6 spheres in each organ j of a subject, averaged across all subjects (Embedded Image), was calculated asEmbedded ImageEq. 7where Embedded Image is the average uptake in organ j of all spheres in subject p for 1 replicate.

4. The variability of sphere uptake across subjects and spheres in each organ j (COVsubj,j) was calculated asEmbedded ImageEq. 8where Embedded Image is as defined in Equation 5. The same 6 spheres could not be inserted in all subjects because the relative locations of the subjects within the scanner with respect to the sphere positions varied; therefore, the variability across subjects included the variability across location within a subject.

Image noise was calculated as the average statistical noise (across the 60 replicates) for a group of voxels in a large region of interest drawn in the liver. A cylindric region of interest with a diameter of 50–80 mm and an axial length of 7 slices (14 mm) was drawn in the liver for this average.

RESULTS

Average Uptake

Figure 2 shows a typical plot of NUVj(1,s,p) as a function of image noise for the 6 spheres in the lung and liver of 1 subject with TOF and non-TOF reconstructions. This plot shows the typical variation seen among the 6 spheres in a given subject. As previously noted (10,11,23,39), the rate of convergence was higher with TOF reconstruction than with non-TOF reconstruction; after 5 iterations, the sphere uptake values with TOF reconstruction had largely converged, whereas more iterations were required for some spheres with non-TOF reconstruction to reach convergence. It was also not apparent whether the NUV achieved with non-TOF reconstruction would ever reach the value achieved with TOF reconstruction. The NUV in the liver was higher than that in the lung for both TOF and non-TOF reconstructions, although the spheres were inserted with the same activity ratio with respect to the average whole-body uptake. This difference was a consequence of partial-volume effects because the spillover from the lower activity in the lung did not contribute as much to the VOI as the spillover from the higher activity in the liver.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Sphere NUV [Embedded Image] for 1 replicate in 1 subject as function of image noise for each of 6 spheres inserted in lung (A) and liver (B), demonstrating typical variations seen across locations and organs. Solid symbols indicate TOF reconstruction; open symbols indicate non-TOF reconstruction. Each curve represents 1 sphere; data points correspond to each of 20 iterations used.

Figure 3 shows Embedded Image for all 6 subjects as a function of image noise. Qualitatively, the difference in NUV between the liver and the lung appeared to be somewhat smaller with TOF reconstruction than with non-TOF reconstruction; this finding was examined in more detail later. As was observed in the results from 1 subject (Fig. 2), the sphere uptake was higher with TOF reconstruction than with non-TOF reconstruction, and the TOF and non-TOF reconstructions appeared to converge to different values.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Average NUV across all 6 spheres [Embedded Image] in given organ for each of 6 subjects as function of image noise in lung (A) and liver (B). Solid symbols indicate TOF reconstruction; open symbols indicate non-TOF reconstruction. Each curve represents 1 subject; data points correspond to each of 20 iterations used.

Variability of Uptake

Figure 4 shows the variabilities of the NUV measurements across replicates (Embedded Image), across locations within an organ (Embedded Image), and across subjects (Embedded Image) as a function of iteration for TOF and non-TOF reconstructions. In both the lung and the liver, all variabilities were smaller with TOF reconstruction than with non-TOF reconstruction. The difference in variability between TOF reconstruction and non-TOF reconstruction was also generally larger in the lung than in the liver. By 5 iterations, Embedded Image and Embedded Image had converged to within 98% and 92% of their values at 20 iterations in the lung and the liver, respectively, for TOF reconstruction (95% and 92%, respectively, for non-TOF reconstruction); however, Embedded Image was slower to converge and continued to increase with more iterations, especially for non-TOF reconstruction.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Variability measures for TOF (left) and non-TOF (right) reconstructions of spheres in lung (A and B) and liver (C and D). Variabilities across replicates (Embedded Image), across sphere locations within organ (Embedded Image), and across spheres and subjects (Embedded Image) are shown as function of iteration. Vertical lines at 5 TOF iterations (6 non-TOF iterations) indicate points (with similar image noise) at which reconstructions were stopped for subsequent analysis.

Average Uptake and Variability of Uptake for Clinical Reconstructions

Clinical image reconstructions are typically not run to convergence but are stopped after a fixed, smaller number of iterations at which the image noise is sufficiently low for good visual image quality and lesion detection. We stopped the TOF reconstruction after 5 iterations. At this stopping point, Embedded Image was within 98% of convergence. We stopped the non-TOF reconstruction at a comparable image noise (6 iterations), although it is evident from Figure 3 that Embedded Image would be farther from convergence (on average, 92% and 97% of the values at 20 iterations in the lung and the liver, respectively). Figure 5A shows Embedded Image achieved in the lung and the liver at this stopping point. The average sphere uptake was higher with TOF reconstruction than with non-TOF reconstruction at matched image noise and was higher in the liver than in the lung. Figure 5B summarizes the variabilities when the reconstructions were stopped early. All variabilities were consistently lower with TOF reconstruction, especially in the lung.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Average uptake and variability at fixed number of iterations and corresponding image noise (5 TOF iterations; 6 non-TOF iterations). (A) Sphere uptake (Embedded Image) in lung and liver, averaged across all spheres in all subjects. (B) Variability of NUV measurements across replicates (Repl.) (Embedded Image), across sphere locations (Loc.) (Embedded Image), and across subjects (Subj.) (Embedded Image) for spheres inserted in lung and liver.

DISCUSSION

The present study showed the impact of TOF reconstruction on lesion quantification under clinically realistic but controlled conditions (i.e., known uptake). In contrast to the conditions in previous studies of the impact of TOF reconstruction on lesion uptake measurements (11,14), the uptake in the spheres was known, so quantitative accuracy could be assessed. Further, unlike the conditions in a phantom study, the nonuniform activity and attenuation distributions seen in patient studies were included to create a situation virtually identical to that in clinical settings. Under these conditions, TOF reconstruction led to improved recovery of sphere uptake (higher NUV) with lower variability (higher precision) across replicates, across locations within an organ, and across subjects. We focused on 10-mm spheres at locations dictated by the positions of the liver and the lung inside the scanner, but we believe that the conclusions would be similar for the various lesion sizes or locations seen in clinical settings.

The increase in NUV observed with TOF reconstruction (factors of 1.5 ± 0.1 in the lung and 1.20 ± 0.05 in the liver at 5 TOF iterations) was consistent with the higher contrast recovery observed in clinical studies with lesions having unknown uptake and with the higher contrast recovery seen for spheres in a large, 35-cm phantom (11). It is interesting, however, that the increase in NUV with TOF reconstruction had no obvious correlation with body mass index, although Karp et al. (11) reported a gain in contrast recovery with TOF reconstruction that increased with patient size. In the present work, the lesions were limited to 10-mm-diameter spheres, and the locations of the lesions were restricted to the lung and the liver; in the previous study, data from patients with disease and lesions with unknown uptake, of various sizes, and at various locations throughout the body were used. In addition, the body mass index had a smaller range in the present study (25–38) than in the previous work (19–46). However, the small numbers of subjects in both studies make it difficult to make a definitive statement about the impact of patient size on the accuracy and precision of lesion uptake measurements with TOF reconstruction.

Because the size of the VOIs was equal to the physical inner diameter of the spheres, the measured NUV included partial-volume effects. To minimize these effects, we also determined the maximum uptake in each sphere (NUVmax), which is analogous to the maximum standardized uptake value commonly used in clinical studies, and we repeated the analysis for 2 subjects. Although the NUVmax was higher than the NUV measured in a VOI by an average of 60%, the results were more variable, as would be expected for a single-voxel measurement: Embedded Image increased by 35%–100%, and Embedded Image increased by 10%–80%. However, the relatively higher measured uptake and lower variability obtained with TOF reconstruction than with non-TOF reconstruction for the NUVmax were consistent with the results presented for the VOIs. Further improvement in the accuracy of the uptake measurement could also be achieved through resolution modeling during reconstruction (20–22). However, because convergence is slowed with resolution modeling, variability across locations and subjects may increase.

The difference between liver and lung spheres was smaller with TOF reconstruction than with non-TOF reconstruction. The ratios of the average liver NUV to the average lung NUV were 1.48 ± 0.06 with TOF reconstruction and 1.85 ± 0.08 with non-TOF reconstruction. Some difference between liver and lung sphere VOIs is expected for images without resolution modeling or partial-volume correction because of different amounts of spillover of activity from outside the sphere into the VOI. This effect is reduced with a smaller VOI. However, differences in the rate of convergence of the OSEM algorithm, which depends on the local activity distribution and is less uniform for non-TOF reconstruction, and differences in the sensitivity of TOF and non-TOF reconstruction algorithms to errors in data correction (24,25) may also play roles.

The increase in the NUV with TOF reconstruction was accompanied by a decrease in the variability (improved precision) of the NUV for all 3 variability metrics studied. At 5 TOF iterations, the variabilities in the lung were 20%–30% lower with TOF reconstruction; in the liver, the variabilities were 10%–20% lower. This improvement in precision with TOF reconstruction can lead to increased confidence in uptake measurements for lesions with unknown activity in clinical studies.

Although it is tempting to compare the gain in the NUV with TOF reconstruction and the theoretic metrics of the gain in the signal-to-noise ratio with TOF reconstruction (4–6), we believe that such a comparison is not the right one for these data. The classical TOF gain metrics were derived from an assessment of image noise, with the assumption that the signal is unchanged, at the center of a uniform object for an analytic reconstruction. With a nonlinear algorithm such as TOF OSEM and the nonuniform emission and attenuation distributions in the present study, the gain in the signal-to-noise ratio with TOF reconstruction was more difficult to quantify. In addition, the focus of the present work was the impact of TOF reconstruction on uptake measurements for lesions in a warm background, not image noise reduction.

The present study was performed with a prototype TOF PET scanner with a TOF resolution of less than 400 ps. Although clinical TOF PET scanners currently have TOF resolutions closer to 600 ps, the impact of timing resolution on the accuracy and precision of lesion uptake measurements is a topic of ongoing investigation. Theoretic and simulation studies suggest an improvement in signal-to-noise ratio gain (40) and higher contrast recovery with better lesion detectability (10) at better TOF resolutions. The healthy volunteers included in the present study were also scanned on a TOF PET system with a 600-ps TOF resolution so that a similar analysis can be performed in the future.

CONCLUSION

The present study showed, with clinical data, that the accuracy and precision of lesion uptake measurements were improved with TOF reconstruction. The findings have implications for individual lesion measurements, for which uncertainty is reduced with TOF reconstruction, yielding more reliable results for improved confidence in diagnostic interpretation. By reducing the underlying intersubject variability of lesion uptake measurements, TOF reconstruction also has the potential to reduce the number of subjects needed for clinical trials.

DISCLOSURE

The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734. This project was supported in part by National Institutes of Health grant R01-CA113941, EU FP7 project SUBLIMA (grant 241711), and a sponsored research agreement with Philips Healthcare. The content is solely the responsibility of the authors. No other potential conflict of interest relevant to this article was reported.

Acknowledgments

We thank Matt Werner for development and implementation of the TOF reconstruction algorithm and data processing, Janet Reddin for assistance with acquisition of the healthy volunteer data, Randy Kulp for system setup and calibration, and Anna Fagin and Kara Napolitano for coordinating the healthy volunteer studies.

Footnotes

  • Published online Mar. 6, 2014.

  • © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

REFERENCES

  1. 1.↵
    1. Allemand R,
    2. Gresset C,
    3. Vacher J
    . Potential advantages of a cesium fluoride scintillator for a time-of-flight positron camera. J Nucl Med. 1980;21:153–155.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    1. Mullani NA,
    2. Markham J,
    3. Ter-Pogossian MM
    . Feasibility of time-of-flight reconstruction in positron emission tomography. J Nucl Med. 1980;21:1095–1097.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Yamamoto M,
    2. Ficke DC,
    3. Ter-Pogossian MM
    . Experimental assessment of the gain achieved by the utilization of time-of-flight information in a positron emission tomograph. IEEE Trans Med Imaging. 1982;1:187–192.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Snyder DL,
    2. Thomas LJ,
    3. Ter-Pogossian MM
    . A mathematical model for positron-emission tomography systems having time-of-flight measurements. IEEE Trans Nucl Sci. 1981;28:3575–3583.
    OpenUrlCrossRef
  5. 5.
    1. Tomitani T
    . Image reconstruction and noise evaluation in photon time-of-flight assisted positron emission tomography. IEEE Trans Nucl Sci. 1981;28:4582–4589.
    OpenUrl
  6. 6.↵
    1. Budinger TF
    . Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med. 1983;24:73–78.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Surti S,
    2. Kuhn A,
    3. Werner ME,
    4. Perkins AE,
    5. Kolthammer J,
    6. Karp JS
    . Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007;48:471–480.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Jakoby BW,
    2. Bercier Y,
    3. Conti M,
    4. Casey ME,
    5. Bendriem B,
    6. Townsend DW
    . Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol. 2011;56:2375–2389.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Bettinardi V,
    2. Presotto L,
    3. Rapisarda E,
    4. Picchio M,
    5. Gianolli L,
    6. Gilardi MC
    . Physical performance of the new hybrid PET/CT Discovery-690. Med Phys. 2011;38:5394–5411.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Surti S,
    2. Karp JS,
    3. Popescu LM,
    4. Daube-Witherspoon ME,
    5. Werner M
    . Investigation of time-of-flight benefit for fully 3-D PET. IEEE Trans Med Imaging. 2006;25:529–538.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Karp JS,
    2. Surti S,
    3. Daube-Witherspoon ME,
    4. Muehllehner G
    . Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med. 2008;49:462–470.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Surti S,
    2. Karp JS
    . Experimental evaluation of a simple lesion detection task with time-of-flight PET. Phys Med Biol. 2009;54:373–384.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Kadrmas DJ,
    2. Casey ME,
    3. Conti M,
    4. Jakoby BW,
    5. Lois C,
    6. Townsend DW
    . Impact of time-of-flight on PET tumor detection. J Nucl Med. 2009;50:1315–1323.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Lois C,
    2. Jakoby BW,
    3. Long MJ,
    4. et al
    . An assessment of the impact of incorporating time-of-flight information into clinical PET/CT imaging. J Nucl Med. 2010;51:237–245.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Daube-Witherspoon ME,
    2. Surti S,
    3. Perkins A,
    4. et al
    . The imaging performance of a LaBr3-based PET scanner. Phys Med Biol. 2010;55:45–64.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. El Fakhri G,
    2. Surti S,
    3. Trott CM,
    4. Scheuermann J,
    5. Karp JS
    . Improvement in lesion detection with whole-body oncologic time-of-flight PET. J Nucl Med. 2011;52:347–353.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Surti S,
    2. Scheuermann J,
    3. El Fakhri G,
    4. et al
    . Impact of time-of-flight PET on whole-body oncologic studies: a human observer lesion detection and localization study. J Nucl Med. 2011;52:712–719.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Surti S,
    2. Karp JS
    . Application of a generalized scan statistic model to evaluate TOF PET images. IEEE Trans Nucl Sci. 2011;58:99–104.
    OpenUrlCrossRefPubMed
  19. 19.
    1. Conti M
    . Focus on time-of-flight PET: the benefits of improved time resolution. Eur J Nucl Med Mol Imaging. 2011;38:1147–1157.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kadrmas DJ,
    2. Oktay MB,
    3. Casey ME,
    4. Hamill JJ
    . Effect of scan time on oncologic lesion detection in whole-body PET. IEEE Trans Nucl Sci. 2012;59:1940–1947.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Schaefferkoetter J,
    2. Casey M,
    3. Townsend D,
    4. El Fakhri G
    . Clinical impact of time-of-flight and point response modeling in PET reconstructions: a lesion detection study. Phys Med Biol. 2013;58:1465–1478.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Prieto E,
    2. Dominguez-Prado I,
    3. Garcia-Velloso MJ,
    4. et al
    . Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET. Clin Nucl Med. 2013;38:103–109.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Karp JS,
    2. Kuhn A,
    3. Perkins AE,
    4. et al
    . Characterization of a time-of-flight PET scanner based on lanthanum bromide. In: Yu B, ed. Conference Record of the 2005 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2005:1919–1923.
  24. 24.↵
    1. Turkington TG,
    2. Wilson JM
    . Attenuation artifacts and time-of-flight PET. In: Yu B, ed. Conference Record of the 2009 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2009:2997–2999.
  25. 25.↵
    1. Conti M
    . Why is TOF PET reconstruction a more robust method in the presence of inconsistent data? Phys Med Biol. 2011;56:155–168.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Hudson HM,
    2. Larkin RS
    . Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601–609.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Reader AJ,
    2. Manavaki R,
    3. Zhao S,
    4. Julyan PJ,
    5. Hastings DL,
    6. Zweit J
    . Accelerated list-mode EM algorithm. IEEE Trans Nucl Sci. 2002;49:42–49.
    OpenUrlCrossRef
  28. 28.↵
    1. Popescu LM,
    2. Matej S,
    3. Lewitt RM
    . Iterative image reconstruction using geometrically ordered subsets with list-mode data. In: Siebert JA, ed. Conference Record of the 2004 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2004:3536–3540.
  29. 29.↵
    1. Lewitt RM
    . Multidimensional digital image representations using generalized Kaiser-Bessel window functions. J Opt Soc Am A. 1990;7:1834–1846.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Matej S,
    2. Lewitt RM
    . Practical considerations for 3-D image reconstruction using spherically symmetric volume elements. IEEE Trans Med Imaging. 1996;15:68–78.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Smith RJ,
    2. Karp JS,
    3. Muehllehner G,
    4. Gualtieri E,
    5. Bernard F
    . Singles transmission scans performed post-injection for quantitative whole-body PET imaging. IEEE Trans Nucl Sci. 1997;44:1329–1335.
    OpenUrlCrossRef
  32. 32.↵
    1. Werner ME,
    2. Surti S,
    3. Karp JS
    . Implementation and evaluation of a 3-D PET single scatter simulation with TOF modeling. In: Phlips B, ed. Conference Record of the 2006 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2006:1768–1773.
  33. 33.↵
    1. Watson CC
    . Extension of single scatter simulation to scatter correction of time-of-flight PET. IEEE Trans Nucl Sci. 2007;54:1679–1686.
    OpenUrlCrossRef
  34. 34.↵
    1. Casey ME,
    2. Hoffman EJ
    . Quantitation in positron emission computed tomography, 7: a technique to reduce noise in accidental coincidence measurements and coincidence efficiency calibration. J Comput Assist Tomogr. 1986;10:845–850.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Bazañez-Borgert M,
    2. Bundschuh RA,
    3. Herz M,
    4. Martinez M-J,
    5. Schwaiger M,
    6. Ziegler SI
    . Radioactive spheres without inactive wall for lesion simulation in PET. Z Med Phys. 2008;18:37–42.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Haynor DR,
    2. Woods SD
    . Resampling estimates of precision in emission tomography. IEEE Trans Med Imaging. 1989;8:337–343.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Dahlbom M
    . Estimation of image noise in PET using the bootstrap method. IEEE Trans Nucl Sci. 2002;49:2062–2066.
    OpenUrlCrossRef
  38. 38.↵
    1. Buvat I
    . A non-parametric bootstrap approach for analyzing the statistical properties of SPECT and PET images. Phys Med Biol. 2002;47:1761–1775.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Conti M,
    2. Bendriem B,
    3. Casey M,
    4. et al
    . First experimental results of time-of-flight reconstruction on an LSO PET scanner. Phys Med Biol. 2005;50:4507–4526.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Conti M,
    2. Eriksson L,
    3. Westerwoudt V
    . Estimating image quality for future generations of TOF PET scanners. IEEE Trans Nucl Sci. 2013;60:87–94.
    OpenUrlCrossRef
  • Received for publication May 30, 2013.
  • Accepted for publication November 1, 2013.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (4)
Journal of Nuclear Medicine
Vol. 55, Issue 4
April 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determination of Accuracy and Precision of Lesion Uptake Measurements in Human Subjects with Time-of-Flight PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Determination of Accuracy and Precision of Lesion Uptake Measurements in Human Subjects with Time-of-Flight PET
Margaret E. Daube-Witherspoon, Suleman Surti, Amy E. Perkins, Joel S. Karp
Journal of Nuclear Medicine Apr 2014, 55 (4) 602-607; DOI: 10.2967/jnumed.113.127035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Determination of Accuracy and Precision of Lesion Uptake Measurements in Human Subjects with Time-of-Flight PET
Margaret E. Daube-Witherspoon, Suleman Surti, Amy E. Perkins, Joel S. Karp
Journal of Nuclear Medicine Apr 2014, 55 (4) 602-607; DOI: 10.2967/jnumed.113.127035
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Total-Body PET System Designs with Axial and Transverse Gaps: A Study of Lesion Quantification and Detectability
  • Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards
  • Benefit of Improved Performance with State-of-the Art Digital PET/CT for Lesion Detection in Oncology
  • Display of 3D Multimodality Cardiac Images With 2D Polar Maps: Simplicity Can Be a Virtue
  • Techniques, Benefits, and Challenges of PET-MR
  • Improving the Detection of Small Lesions Using a State-of-the-Art Time-of-Flight PET/CT System and Small-Voxel Reconstructions
  • Update on Time-of-Flight PET Imaging
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • instrumentation
  • PET
  • research methods
  • Positron Emission Tomography
  • Time-of-Flight PET
SNMMI

© 2025 SNMMI

Powered by HighWire